Pharmacist-led Continuous Glucose Monitoring

This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)

Inclusion Criteria: * type 2 diabetes * hemoglobin A1c ≥ 8% * compatible smartphone with FreeStyle Libre 2 or Libre 3+ continuous glucose monitoring system * current use and access to a glucometer for self-monitoring of blood glucose Exclusion Criteria: * any continuous glucose monitor use within 6 months prior to study enrollment * pregnant and planning to become pregnant during study time frame * history of hypoglycemia requiring third party assistance * history of diabetic ketoacidosis or hyperosmolar hyperglycemic state within 6 months prior to study enrollment * known allergy to medical grade adhesives * current use of systemic steroids for any medical condition * current use of dialysis